Object. To manage refractory upper-limb spasticity, selective peripheral neurotomy (SPN) is proposed when the spastic muscles to be treated are under the control of a single or a few peripheral nerves. The aim of this study was to assess prospectively the long-term effects of SPN.
PASTIC disorders are sometimes disabling and their treatment can be very challenging. Spasticity leading to disequilibrium in the muscular tonic balance of limb segments is considered harmful. Excess spasticity in the upper limb may mask residual motor function, makes passive movement difficult, hinders comfort in daily activities, generates pain, and creates a nonaesthetic appearance. In cases in which no further improvement can be achieved despite oral medication and physical therapy, more aggressive therapies such as botulinum toxin injections, neurosurgery, and/or neuroorthopedic surgery can be considered.
Carefully selecting patients for surgery is necessary to obtain appreciable results. 16 Different approaches can be considered including neurosurgical procedures at peripheral (SPN or rhizotomy) 8, 15 or central (surgery in the DREZ [DREZotomy] or chronic intrathecal infusion of antispasticity drugs) levels. Orthopedic surgery may be indicated when joint deformities and muscle contractures are present.
Neurosurgical procedures aim to reestablish the tonic balance between agonist and antagonist muscles by reducing the excess of spasticity, which must be achieved as selectively as possible without abolishing useful muscle tone or decreasing residual motor and sensory functions. For treatment of upper-limb spasticity, two neurosurgical procedures can be considered: DREZotomy and SPN. 8 The former procedure is performed to alleviate diffuse spasticity in the limb, 20 the latter when spasticity is restricted to muscles subject to the control of a single or only a few peripheral nerves.
The basic phenomenon underlying spasticity is hyperexcitability of the stretch reflex. 12 Muscular nerves include afferent fibers of the stretch reflex to the spinal cord, especially myelinated Ia and Ib fibers and efferent motor neuron axons. Partial section of these fibers via SPN leads to a decrease in spasticity by acting on both the afferents and efferents of the stretch reflex. 12 The use of peripheral neurotomy was first described for lower-limb spasticity by Lorenz 14 in 1887 to treat spastic hip adduction via obturator neurotomy. In 1912 Stoffel 21 first performed median nerve neurotomy for upper-limb spastic-ity initially by sectioning motor fascicles inside the trunk of the median nerve and later, at a more distal level, by dividing muscular branches to avoid sensory disorders. In later years, neurotomies were rarely applied because nerve block techniques through alcoholization were developed. [22] [23] [24] In 1976 Gros and colleagues 11 reintroduced SPNs and refined the techniques by using the neurosurgical advances in microsurgery and mapping through intraoperative electrical nerve stimulation. Selective peripheral neurotomies were mostly performed by neurosurgeons for the treatment of lower-limb spasticity, with limited use for upper-limb spasticity due to the presence of more complex spastic deformities. In 1988 Sindou and Mertens 19 introduced testing methods with local anesthetic agents and published long-term results on SPN of the tibial nerve for treating the spastic foot.
Only a limited number of published studies 5, 9, 11 deal with upper-limb spasticity treated with SPN, and data from these studies offer no details regarding the assessment of functional effects and/or long-term results. Brunelli and Brunelli 5 were the first to give details on the surgical techniques of SPN for the spastic upper limb, providing overall clinical results without describing the functional assessments in patients. Therefore, we conducted a prospective clinical study in patients with upper-limb spasticity to assess long-term functional results of SPN.
Clinical Material and Methods

Patient Population
Thirty-one patients with harmful upper-limb spasticity despite optimal oral medication and physical therapy were included in this study. The cohort included 20 male (64.52%) and 11 female patients (35.48%) with a mean age of 38 years (range 13-66 years).
Spasticity was caused by cerebral stroke in 13 patients (41.9%), brain trauma in 13 (41.9%), cerebral palsy in three (9.7%), and cerebral tumor in two (6.5%). Cognitive function according to the Mini-Mental State Examination was within the normal range in 20 patients and mildly impaired in 11 patients. Language function was normal in 20 patients, mildly impaired in eight, and severely impaired in three. The dominant side (right-or left-handed) was ipsilateral to the spastic limb in 15 patients and contralateral in 15. Hemispatial neglect was observed in nine patients.
Clinical Presentation
Thirty patients had unilateral and one patient (with cerebral palsy) had bilateral upper-limb spasticity. Shoulder spasticity was absent or mild in all patients and was not considered severe enough to require surgery. Elbow spasticity in flexion was present in 15 patients: seven had harmful elbow spasticity with mild distal spasticity and eight had associated severe distal spasticity and were candidates for surgery. Flexion spasticity of the elbow was mediated mainly by the biceps brachii and brachialis muscles innervated by the musculocutaneous nerve.
Twenty-five patients had harmful spasticity which was distal to the elbow: forearm pronation mediated by the pronator teres and quadratus muscles innervated by the median nerve; wrist flexion mediated by the flexor carpi radialis, palmaris longus, and flexor carpi ulnaris muscles innervated by the median and ulnar nerves; wrist ulnar deviation mediated by the flexor carpi ulnaris muscle innervated by the ulnar nerve; finger flexion mediated by the flexor digitorum superficialis and profundus muscles innervated by the median and ulnar nerves; thumb flexion mediated by the flexor pollicis longus muscle innervated by the median nerve; and thumb adduction mediated by the adductor pollicis muscle innervated by the ulnar nerve. All patients had predominant extrinsic hand muscle spasticity, and none had pure intrinsic hand muscle spasticity. Ten patients had thumb-in-the-palm deformities. Six had severe flexion of the elbow induced by walking. Results of the sensory discrimination test revealed that the affected upper limb was normal in 12 patients, mildly impaired in 17, and severely impaired in two.
Previous Antispasticity Treatment
On initiation of the study, 22 patients were taking oral antispasticity drugs with partial effects, whereas the other nine patients had stopped their treatments because of either side effects (two patients) or loss of efficacy (seven patients). Eighteen patients had undergone regular physical therapy as outpatients, and 13, institutional physical therapy.
Seven patients had previously undergone surgery: five received microsurgical DREZotomy with an incomplete effect on hand spasticity and had two orthopedic surgery (direct and indirect tendon lengthening). We noticed a beneficial effect of botulinum toxin in 12 patients, who were then referred for surgery due to the decrease of the effect over time and/or the patient's wish to have more permanent treatment.
Study Design
All patients were recruited for the study between 1993 and 2003. The inclusion criteria were as follows: harmful upper-limb spasticity, spasticity refractory to optimal oral medication, spasticity refractory to optimal physical therapy, absence of active disease requiring other specific surgical or medical treatment, and positive anesthetic block test. Exclusion criteria were as follows: uncooperative patients, insufficient intelligence quotient, severe irreversible muscular contractures and osseous deformities, pure intrinsic hand muscle spasticity, negative anesthetic block test, and contraindication to surgery or anesthesia.
Preoperative Clinical Assessment
Patients were assessed by a multidisciplinary team comprising a neurosurgeon, a neurologist, a physical therapist, an occupational therapist, and an orthopedic surgeon. Clinical evaluation of the upper limb was noted on a preestablished chart, which was completed preoperatively. On the chart we recorded the spasticity of each muscular group of the upper limb, according to the Ashworth Scale (Table  1) ; the resting position of every joint of the upper limb; and the active amplitude and antagonist muscle strength, that is, extension and flexion of the elbow; pronation and supination of the forearm; extension and flexion of the wrist; extension and flexion of the fingers; and extension, flexion, abduction, and adduction of the thumb. Swan-neck and thumb-in-the-palm deformities were noted if present. We also noted the results of a clinical sensory discrimination test. Pain evaluation of the affected upper limb was conducted using the VAS (0-100). Functional assessment was performed by an occupational therapist through the evaluation of gross and fine prehension. A global function score was determined: 0, impossible prehension; 1, possible passive prehension with help; 2, prehension present but incorrect; and 3, functional prehension. Active opening of the hand was evaluated. Press-paper function, which is the ability to immobilize a paper between the hand and a table, allowing writing with the other unaffected hand, was noted if present. Daily activities were also assessed, especially hygiene, dressing, eating, working, and leisure.
Preoperative Nerve Block Tests
Temporary anesthetic blocks were performed to determine in a few hours whether spontaneous deformities were a result of muscle spasticity alone or occurred in association with additional orthopedic complications. The test was also used to assess the residual motor function of antagonist muscles, mainly extensor muscles. Such blocks were performed by injecting 3 ml 0.25% bupivacaine in the vicinity of the musculocutaneous and/or median and/or ulnar nerve trunks.
A positive anesthetic block test was defined as a considerable decrease in upper-limb deformities and/or functional improvement (active opening of the hand and prehension) and/or improvements in conducting daily activities (especially self-care, dressing, and eating) and/or an improved aesthetic appearance, as assessed by the multidisciplinary team.
If the test provided evidence of musculotendinous contractures in association with spasticity, complementary orthopedic surgery was discussed (that is, tendon lengthening).
Definition of Surgery Goals
After assessment by the multidisciplinary team, patients were selected for surgery with two different goals: a functional goal, that is, functional improvements (active opening of the hand and prehension) were considered; and/or a comfort goal, that is, improvements in nursing, hygiene, dressing, eating, working, leisure, aesthetic appearance, and/ or pain relief were considered. Patients and/or family members participated in defining the aim of the surgical procedure, which was the basis of the therapeutic contract established with the medical team.
In this study, SPN was oriented toward functional improvement in 11 patients (35.5%) and improvement in daily comfort in 20 patients (64.5%).
Postoperative Clinical Assessment
All patients underwent the same multidisciplinary assessment 6 months after surgery and at the last follow-up visit: Ashworth Scale for all muscle groups in the upper limb; resting position of every joint in the upper limb; complete analytical screening of active movement (amplitude and motor strength) of each joint of the upper limb in all directions; evaluation of gross and fine prehension as well as active opening of the hand; use of the limb in daily activities; assessment (improvement, degradation, or no modification) of daily activities such as self-care, hygiene, dressing, eating, working, or leisure as reported by the patient, the family, and the physical therapist or nurse taking care of the patient; improvement, degradation, or no modification in aesthetic appearance and pain; any change in oral medication for spasticity; and the mean degree of global satisfaction of the patient and the people caring for the patient, according to a VAS ranging from 0 to 100.
All patients were systematically reexamined as outpatients at 2, 6, and 12 months after surgery and also underwent long-term follow-up evaluations. The mean follow-up period in this study was 4.5 years (range 1-10.2 years).
Statistical Analysis
Preoperative and postoperative resting joint position, passive and active range of motion, muscle strength, Ashworth Scale score, and function scores were compared using the Wilcoxon test. A probability value less than 0.05 was considered statistically significant. The postoperative status at the last follow-up evaluation was compared with the preoperative status.
Surgical Technique
There was a mean delay of 6.8 years (range 1-26 years) between the onset of neurological disorders and surgery. One patient underwent bilateral surgery.
A complete preoperative evaluation was essential to establishing an operative program that outlined the targeted spastic muscles and the amount of denervation required for each spastic muscle: 50% for mild spasticity (Ashworth Scale Score 2), 65% for severe spasticity (Ashworth Scale Score 3), and a maximum of 80% for intense spasticity (Ashworth Scale score Ͼ 3; Table 2 ). The need for associated orthopedic surgery during the same operative procedure was also determined according to the results of the preoperative anesthetic block tests.
Sixty-four SPNs were performed on 32 upper limbs at different levels: musculocutaneous nerve (15 cases), median nerve (25 cases), and ulnar nerve (24 cases).
General anesthesia was induced without long-lasting curarization to detect the motor responses elicited by bipolar electrical stimulation of motor branches during surgery. These responses were used for nerve identification. The pa-
J. Neurosurg. / Volume 104 / February, 2006
Selective peripheral neurotomy for upper-limb spasticity 217 tient was placed supine, with the upper limb at a 70 to 90s houlder abduction. The limb was sterilized and draped so that the surgeon could check all the muscular responses induced by nerve stimulation. Skin incision ( Fig. 1 ) and subcutaneous sharp dissection were performed according to the corresponding nerve (musculocutaneous, median, or ulnar). With the aid of an operating microscope, the muscular branches were dissected and identified according to the anatomy and more precisely by the muscular responses to bipolar electrical stimulation (NIMBUS Multifunctional Stimulator; Newmedic International, Toulouse, France) at the lowest intensity to avoid electrical diffusion (1-mA maximum).
Musculocutaneous Nerve Neurotomy. Skin incisions were made longitudinally, extending from the inferior edge of the pectoralis major muscle, medial to the biceps brachii muscle, and down for 4 to 5 cm. The superficial fascia was then incised between the biceps muscle laterally and the brachialis muscle medially. The space where the musculocutaneous nerve lies anterior to the brachialis muscle was then dissected. With the aid of the operating microscope, the epinerium was incised to allow dissection of the nerve fascicles. Motor fascicles were dissociated from sensitive fascicles with the help of a nerve stimulator.
Median Nerve Neurotomy. A skin incision was begun 4 to 5 cm above the flexion line of the elbow, medial to the biceps brachii tendon, passing through the elbow, and curving before reaching the junction of the upper and middle third of the anterior forearm (the convexity of the curve was oriented laterally). Thereafter, the median nerve was sought medial to the brachial artery and identified at the elbow, deep under the lacertus fibrosus, which was then cut. A sharp dissection was performed to separate the branches of the median nerve: the pronator teres muscle belly (two heads) was retracted medially and distally to inspect its muscular branches ( Fig. 2A) . This muscle was then retracted laterally and up while the flexor carpi radialis muscle was pulled down medially, so that the muscular branches of the flexor carpi radialis and flexor digitorum superficialis muscles were visible. Finally, the latter was retracted medially, uncovering the branches of the flexor digitorum profundus, flexor pollicis longus, and pronator quadratus muscles. These latter muscular branches can occur as separate branches or remain together in the distal trunk of the anterior interosseous nerve. It is sometimes useful to divide the fibrous arch of the flexor digitorum superficialis muscle to make the dissection easier. Ulnar Nerve Neurotomy. A separate arched skin incision was performed to expose the ulnar nerve in the medial part of the elbow. After subcutaneous dissection, the ulnar nerve was identified medial to the medial epicondyle, where it enters between the two heads of the flexor carpi ulnaris muscle whose motor branches were identified. More distally, the branches of the medial half of the flexor digitorum profundus muscle were identified.
After dissection and identification of all the motor branches through analysis of the motor response to electrical stimulation (Fig. 2B) , branches of the muscles that were responsible for harmful spasticity were marked separately with colored tapes. Based on the preoperative evaluation and subsequent surgical program (Table 2 ) and using the operating microscope, variable portions (50-80%, depending on the degree of spasticity) of the isolated motor branches or fascicles were resected near the muscle to be sure that only muscular branches were cut. The resection was performed 5 mm from the proximal stump (Fig. 2C) , which was coagulated with bipolar forceps (Fig. 2D) to prevent the regrowth of fibers. In the event of multiple nerve branches, complete sectioning of one or more branches could be easily performed until the necessary amount of nerve was sectioned.
The effect of each nerve resection on spasticity was evaluated by comparing muscle responses to electrical stimulation proximal and distal to the resected portion of the nerve. If the response following proximal stimulation was still intense, further resection could be performed. We intended to sufficiently decrease motor innervation to avoid recurrence of spasticity by the take-over phenomenon (adoption by surrounding motor fibers or reinnervation of the muscular fibers denervated following neurotomy).
Associated Orthopedic Surgery. When muscular contractures were apparent from the anesthetic block tests, orthopedic surgery was performed during the same procedure. In other cases, orthopedic surgery was considered only after the 6-month neurotomy assessment. According to the preoperative program, 11 patients (35.5%) underwent orthopedic surgery for irreversible deformities either during the same procedure (six patients) or at a later stage (five patients).
Postoperative Care
The limb was raised to avoid edema and mobilized as soon as possible. Casts and splints were used only when associated orthopedic surgery had been performed. Physical therapy began on the 2nd postoperative day. Anticoagulation therapy was administered for 10 days. Patient were discharged on the 7th postoperative day and immediately began a physical and occupational therapy program at a rehabilitation center for at least 4 weeks, continuing as outpatients for a period of 2 months afterwards.
Patient characteristics are shown in Table 3 .
Results
Upper-Limb Spasticity
Targeted Muscular Group. Selective peripheral neurotomy for upper-limb spasticity tion of the Ashworth Scale score before and after surgery, showing a significant decrease in spasticity in all muscular groups subjected to surgery. Elbow flexion spasticity decreased significantly (p = 0.001) in patients who had undergone musculocutaneous nerve neurotomy. Patients who had median and/or ulnar nerve neurotomy showed a significant decrease (p Ͻ 0.001) in the Ashworth Scale score for forearm pronation, wrist and finger flexion, and thumb flexion and adduction.
Distant and Collateral Effects. Distant effects of neurotomies were observed. Isolated musculocutaneous neurotomy in seven patients decreased distal spasticity without reaching statistical significance. Isolated median and/or ulnar nerve neurotomy decreased spasticity statistically significantly in the proximal muscles of the elbow (p = 0.002). Despite the fact that surgery was not directly targeted to thenar muscles, intrinsic hand spasticity leading to thumb-in-thepalm deformities was reduced (Table 4) : this deformity was corrected after surgery in six of 10 patients.
Of the 15 patients who had undergone musculocutaneous neurotomy for spastic elbow, six displayed severe elbow flexion induced by walking. Postoperatively, this dynamic spasticity disappeared completely, with marked gait improvement due to better stability in the upper limb.
Resting Position and Range of Motion
Patients (15 patients) who had undergone musculocutaneous neurotomy had elbow assessments (Fig. 3) . Patients who had undergone median and/or ulnar neurotomy had distal joint assessments. Table 5 summarizes the improvements observed in the resting joint position, active amplitude, and motor strength after surgery. All improvements were statistically significant.
Hand Function
In the 11 patients who had undergone surgery with a functional goal, the respective preoperative gross and fine prehension scores were 0.91 (SD 0.83) and 0.82 (SD 0.75); the respective postoperative scores were 2.45 (SD 0.69, p = 0.003) and 2.36 (SD 0.81, p = 0.003). Among these 11 patients, nine (81.8%) acquired active hand opening after surgery, and eight (72.7%), the press-paper function.
Among the 20 patients who had undergone surgery with the aim of gaining more comfort, a one-grade improvement in gross prehension was achieved in five and in fine prehension in three. Only two patients from this group acquired active hand opening, and two, the press-paper function. 
Daily Activities and Aesthetic Appearance
Well-documented improvements in daily activities and aesthetic appearance, as declared by the patient and the patient's family, physical therapist, and nurse, were as follows: self-care, 26 patients (84%); hygiene, 28 patients (90%); dressing, 23 patients (74%); eating, 15 patients (48%); working (that is, adapted work), 10 patients (32%); leisure, 21 patients (68%); and aesthetic appearance, 27 patients (87%). Table 6 shows the overall improvements in the entire patient series according to the predefined aim of surgery: function or comfort.
Painful Spasticity
Severe painful spasticity, ranging from 70 to 90 on the VAS, affected four patients preoperatively. All patients (100%) were pain free after surgery (0 on the VAS).
Influence of Surgical Side and Hemispatial Neglect
Fifteen patients underwent surgery on the nondominant side, and all used the corresponding upper limb in their daily activities after surgery. The average degree of satisfaction (VAS Score 59.5) was similar to that in patients who had undergone surgery on the dominant side (VAS Score 63.5).
Despite the fact that nine patients showed hemispatial neglect of the affected limb, eight were able to use that limb in daily activities after surgery.
Oral Medication Intake
Twenty-two patients were taking an oral antispasticity medication before surgery. By the last follow-up visit, eight (36%) had stopped treatment after surgery, four (18%) had decreased medication intake, and the remaining 10 patients (46%) remained on the same treatment mainly due to associated spasticity of the lower limb.
Degree of Patient Satisfaction
On the basis of a VAS ranging from 0 to 100, the mean degree of patient satisfaction was 61.5 Ϯ 24.6 (mean Ϯ SD, range 25-100). The mean degree of satisfaction for the family, physical therapist, or nurse was 64.15 Ϯ 19.47 (range 30-100). During the last follow-up visit, when asked, "If you had not had an operation in the past and in view of the beneficial results obtained from surgery, would you agree to undergo the same surgery now?", 30 of 31 patients said that they would undergo the surgery.
When we compared the preoperative therapeutic contract established with the patient and/or the patient's family de-
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Selective peripheral neurotomy for upper-limb spasticity 16 patients underwent median and/or ulnar neurotomy only. Elbow spasticity in flexion was ameliorated in 16 patients who had undergone median and/or ulnar neurotomy without musculocutaneous neurotomy (p = 0.002). There was also a slight decrease in the Ashworth Scale score (without reaching statistical significance) for the muscle tone distal to the elbow in the seven patients who had undergone musculocutaneous neurotomy.
fining the putative effects of surgery and the postoperative results, we found that the aims of the contract had been achieved in 30 patients (96%).
Recurrence of Spasticity
At the 6-month follow-up visit, spasticity recurred in the upper limbs in five patients ([15.6%] Cases 1-3, 6, and 10) who had undergone surgery. Three patients experienced partial recurrence, which was considered by the patient and the multidisciplinary team as insufficient to justify a repeated intervention. The other two patients underwent repeated surgery 12 and 14 months after the first operation, with a long-term result equivalent to that obtained after the initial surgery.
Postoperative Complications
Complications occurred in five patients (15%). Two had local postoperative hematoma, which in one case required surgical evacuation. Two patients experienced transitory hypesthesia of the anterior part of the forearm because of the surgical approach and a lesion of the subcutaneous sensitive branches. One patient suffered a transient paresis in the wrist and finger flexors for 3 months.
No other major complication was observed in this series.
Discussion
In this study we discuss the principles and results of SPN in the treatment of upper-limb spasticity in a series of 31 patients following analytical and functional assessment.
Purpose of Preoperative Testing
Anesthetic Block Test. The anesthetic block test temporally obstructs a selected peripheral nerve (musculocutaneous, median, and/or ulnar nerve), thereby determining the contribution of spasticity and/or musculotendinous contractures and/or articular ankyloses to deformities. Thus, it is a valuable, short-lived preoperative test that can predict the usefulness of localized SPN treatment of spasticity. Residual masked active motility of antagonists can also be detected, which can predict functional improvement. Furthermore, the conditions created by the test give the patient an opportunity to appreciate what to expect after surgery.
Note, however, that this test does have some drawbacks, such as associated sensory block even when the most advanced selective local anesthetic drugs are used, as well as significant paralysis of spastic muscles that outlasts the effects of the neurotomy.
This test was valuable in all patients in our study, as a means of predicting the effect of surgery and confirming the indication for surgery, which had been established after the multidisciplinary team evaluation.
Botulinum Toxin Injection. With recent and wider indications for botulinum toxin injections in the treatment of spasticity, this technique has been validated as part of the therapeutic arsenal for spastic upper limb. Several studies [2] [3] [4] have been conducted since the first randomized, doubleblind, placebo-controlled trial performed by Simpson and colleagues, 18 who proved the safety, efficacy, and functional improvement in upper-limb spasticity following botulinum toxin injections. In our study, this technique was proposed by the multidisciplinary team as a first choice and performed in the last 12 patients included in the series with beneficial effects. Patients were then referred for surgery either because of a decrease in the therapeutic effect following repeated injections or because the patient wished to receive more permanent relief without having to be dependent on a repetitive technique. Results obtained following surgery in the 12 patients were similar to the beneficial effects observed after the first toxin injection. Given that a complete evaluation of the effect of the botulinum toxin was not the purpose of this prospective study, we did not compare the results obtained after botulinum toxin injection and those after surgery.
Surgical Technique
Thanks to advances in microsurgery and intraoperative electrical stimulation, SPN is more accurate and leads to * Values are presented as the means Ϯ SDs. Resting position and active amplitude represent the average angles (in degrees), whereas strength represents the average score. Note that the analytical assessment was performed only in patients who had undergone musculocutaneous neurotomy for the elbow (15 patients) and in those who had undergone median and/or ulnar neurotomy with a functional goal (11 patients).
† Resting angle was flexion degree for the elbow and wrist, pronation angle for forearm, and the sum of flexion angles at different joints of the fingers and thumb.
‡ Active amplitude was flexion/extension for the elbow, wrist, fingers, and thumb; pronation/supination for the forearm; and adduction/abduction for the thumb. § Muscle strength was measured for antagonist muscles as follows: extension of the elbow; supination for the forearm; extension for the wrist, fingers, and thumb; abduction for thumb.
more consistent results than the primitive technique described by Stoffel. 21 The key to the SPN's success is to identify accurately and to cut the correct amount of selected motor branches.
The surgical approach for median nerve neurotomy involved exposing only the proximal third of the anterior forearm at the midline. This limited approach allowed us to access all the motor branches of interest, including distal ones such as the branches for the pronator quadratus and flexor pollicis longus muscles, under the fibrous arch of the flexor digitorum superficialis muscle. Thus, we consider that appropriate exposure of all the motor branches of the median nerve can be achieved through a limited surgical approach in comparison with the classic sinuous skin incision extending from the elbow to the wrist. 5, 11, 14 To avoid sensory fascicle damage during SPN and to be as selective as possible with regard to the motor branches of a given muscle, we performed neurotomy distally rather than proximally in the motor branches or in the nerve trunk, except for the musculocutaneous nerve where microsurgical dissection of the trunk allowed us to separate motor from sensory fascicles through electrical stimulation. Such selective sectioning, which was confined to distal muscular branches, could explain why we observed no painful neuroma and no late neuropathic or causalgic pain in the series despite the long follow-up period.
The extent of resection for each spastic muscle remains the most critical point. The aim of surgery is to reestablish equilibrium between agonist and antagonist muscles. Indeed, the voluntary motor control of spastic muscles must be maintained to achieve maximal functional results. The section must therefore be determined simultaneously to avoid the loss of motor function and recurrence of spasticity (Table 2) . We observed this latter phenomenon in five patients in whom recurrence could be related to peripheral mechanisms: 1) reinnervation by nerve fibers proximal to the section; and 2) muscle reinnervation through sprouting from residual motor nerve fibers. Brunelli and Brunelli, 5 who developed SPN for upper-limb spasticity, mostly performed neurotomy in two surgical procedures separated by a period of 6 months to treat the frequent recurrence of spasticity. We consider one-stage surgery appropriate if the extent of resection is well adapted to the preoperative plan and the degree of spasticity in each muscle is taken into account. Note that the fascicles must be resected over a length of 5 mm and the proximal stump coagulated to avoid regrowth of the proximal motor nerve fibers, which consequently reduces the recurrence of spasticity.
The preoperative delay is important given that early surgery is not indicated until the patient reaches a stable neurological status, and late surgery is often unfruitful because of the presence of permanent orthopedic deformities. The ideal timing to stop the evolution of spasticity and to prevent the appearance of irreversible deformities would involve performing the neurotomy when more conservative treatments fail. In the present series, the mean delay before surgery was great: 6 to 8 years. This delay most probably explains the need for associated orthopedic surgery in 35% of cases. The most appropriate time for surgery can only be determined through regular follow-up evaluation by a multidisciplinary team; when spasticity can no longer be controlled, surgery must be discussed in selected cases and generally after botulinum toxin injections are considered.
There is no doubt that associated orthopedic surgery improves the final results in patients with a long history of spasticity and associated retractions and deformities. In such cases, it seems logical to perform selective neurotomy as a first approach. An initial decrease in spasticity through SPN leads to longer lasting results following orthopedic surgery compared with the results obtained after orthopedic surgery alone. Note that orthopedic surgery alone is limited to the upper limb with dominant irreversible deformities. 25 
Results of Selective Microsurgical Neurotomy
Improvement in the components of the analytical assessment-that is, spontaneous position, active motion, and motor strength-was observed in all patients who had undergone surgery with a functional goal. Spasticity improved not only in muscles under the control of the nerve subjected to surgery, but also in groups of muscles not innervated by the resected nerve. Thus, decreasing focal spasticity leads to a more diffuse effect, as has already been observed in other series. 15, 19 Assessment of the upper limb showed statistically significant postoperative improvement in all patients who had undergone surgery with a functional aim. In this group, a significant number of patients acquired active hand opening abilities and/or press-paper function, which are both considerably important in daily hand use. Even five patients who had undergone surgery with a comfort goal displayed some functional improvements that had not been initially considered as a surgery goal. Improvements in basic daily activities and aesthetic appearance were observed in all patients, regardless of the aim of surgery. Other benefits of surgery included gait improvement because of a better position of the upper limb as well as complete resolution of severe pain due to harmful spasticity. More than one half of the patients decreased or completely stopped oral antispasticity medication, with the subsequent disappearance of any side effects. All of these improvements were satisfying for both the patients and their families, and in most cases had a positive psychological impact.
It is interesting to note that patients who had undergone surgery on the nondominant side (15 patients) or showed hemispatial neglect (nine patients) experienced from functional improvement. One explanation for this result may be that the neurotomy itself actually encourages patients to focus on the limb subjected to surgery-even if it is on the
J. Neurosurg. / Volume 104 / February, 2006
Selective peripheral neurotomy for upper-limb spasticity 223 21 with inconsistent results, most probably due to the lack of a precise technique and a valid intraoperative mapping procedure. Sensory side effects and postoperative neuropathic pain led him to perform neurotomies of the distal muscular branches rather than intrafascicular neurotomies of the trunk of the median nerve, as had been previously performed. In 1980 Cahuzac 7 reported on six cases of spastic pronation of the forearm caused by cerebral palsy in children. This author performed complete resections of the muscular branches of the pronator teres muscle, leaving innervation of the pronator quadratus muscle intact. Supination was improved in all patients. In 1983 Brunelli and Brunelli 5 published the results of a series consisting of 53 patients who had undergone median and ulnar nerve neurotomies. They noted improvement in all patients without giving detailed results. They followed an extensive sinuous approach for the entire anterior forearm. Indeed, 40 of the patients in that study underwent surgery in two stages and three underwent three-stage procedures. The Brunellis concluded that in most cases a second operation was necessary 6 months after the initial procedure because of the difficulty associated with quantifying the extent of resection required during the first operation. The aim of the second operation was to complete the initial nerve resection while taking into account the clinical results obtained 6 months after the first procedure. We believe that a one-step operation is sufficient in most cases in which adequate resection is performed to prevent a recurrence in spasticity.
Garland and colleagues 10 published the results from a series of 30 patients who had undergone musculocutaneous neurotomy in nonfunctional upper limbs for spastic elbow. The nerve sections were total, nonselective, and associated when necessary with a release of soft tissue. A decrease in the spasticity of the elbow flexor muscles was observed in all patients. In their series, Purohit and associates 17 performed selective neurotomy of the musculocutaneous nerve in 75 spastic elbows in flexion and reported data from a mean follow-up period of 17 months. They observed no recurrence of spasticity with excellent results in 62.66% and some degree of residual spasticity in 37.33% of cases. In the patients in our study, the mean postoperative Ashworth Scale score for the elbow flexors in those who had undergone musculocutaneous neurotomy (15 patients) was 0.8 Ϯ 0.77, indicating excellent results in all patients. This outcome is probably due to the fact that the resections in our series were more extensive than those performed by Purohit and colleagues.
Alternatives to Neurotomy
Patients suffering from severe harmful spasticity of the upper limb can be treated using several techniques other than oral antispasticity medication and physical therapy. Such treatments include botulinum toxin, 2-4,18 nerve alcoholization, 22, 23 intrathecal baclofen, 1,6,13 microsurgical DREZotomy, 16 and SPN. [8] [9] [10] 15 Recently, botulinum toxin has progressively gained popularity with reproducible results in regard to upper-limb spasticity. [2] [3] [4] 18 Since the neurologists at our hospital introduced this technique, the multidisciplinary team now considers it a first-choice treatment. Botulinum toxin injections are less invasive than surgery although they do not produce permanent effects and require repeating. In addition, the therapy is costly because it requires multiple injections. Patients who initially experienced beneficial effects of such a treatment were referred for subsequent SPN when there was a progressive decrease in the observed effect after multiple repetitive injections or when the patient and his or her family wished for a more permanent result. The beneficial impact of the toxin injections is indicative of the effect that will be observed after surgery. Indeed, the toxin and SPN both decrease the strength of the spastic muscle, even though the therapeutic target is different (neuromuscular junction for the toxin and nerve for the SPN).
Alcoholization of motor sites 22, 23 can be an alternative to neurotomy, but the effects are quantitatively less selective, transitory, and inconsistent and can sometimes lead to complications such as pain or inflammation. This technique is therefore no longer used in our department for the treatment of upper-limb spasticity.
Intrathecal baclofen therapy 1, 6, 13 can decrease spasticity in the upper limb and has the advantage of being a nonablative technique and thus is reversible. Note, however, that its effect is less pronounced on upper-limb spasticity than on lower-limb spasticity. It leads to a mean decrease of 0.6 to 1.2 points 6,13 according to the Ashworth Scale score for the spastic upper limb, whereas SPN leads to a mean decrease of 3 points (Table 4 ). Intrathecal baclofen administration seems appropriate when spasticity is diffuse in the upper and lower limb, and neurotomy is more appropriate for focal spasticity. Indeed, SPN can unmask residual motor function in antagonists of spastic muscles, which can lead to functional improvement. Baclofen decreases the tone of the entire muscle, thus making it difficult to assess functional improvement. Finally, in doubtful cases, an intrathecal baclofen test can be performed and compared with an anesthetic block test to choose the appropriate method for spasticity treatment.
Microsurgical DREZotomy is a valuable alternative to microsurgical SPN, especially when harmful spasticity is more diffuse and involves all of the joints from the shoulder to the fingers. 20 
Conclusions
When optimal oral antispasticity medication and physical therapies fail to stabilize upper-limb spasticity, then SPN may be indicated in patients who wish to benefit from a permanent antispasticity treatment. Preoperative anesthetic block tests were mandatory to select candidates for surgery. After preoperative selection by a multidisciplinary team, surgical goals were defined in collaboration with patients as either functional (hand function improvement) or comfort (daily activity improvement only). Surgery led to statistically significant improvement in spasticity according to the Ashworth Scale, resting position, active amplitude, and muscle strength of the affected joint and muscles. Hand function improved in all patients who had a functional surgical goal. Daily activities clearly improved in all patients. Spasticity-generated pain (originating from muscles or joints) resolved in affected patients. Minor transient surgical complications were observed.
Data in this study show that in appropriately selected patients suffering from severe harmful upper-limb spasticity resistant to conservative therapy, SPN leads to long-term satisfactory improvements in limb function and/or patient comfort. Surgery, for which timing is of great importance, must be performed before irreversible joint deformities appear, which are major drawbacks to obtaining good results.
